Content Management Policy

Owner: ELEVIS LTD · Effective 11 August 2026

Scope

This policy covers public website text, in-product guidance, knowledge-base articles, support templates, safety notices, release notes and legal pages. It does not convert user-entered tracker records into Elevis-authored clinical content.

Roles and approval

• Author: drafts against an identified user need and cites authoritative sources where factual accuracy matters.
• Reviewer: checks clarity, accessibility, product accuracy, privacy and security.
• Approver: an authorised administrator publishes. Medical or medicines-related guidance requires an appropriately qualified external reviewer before it can claim clinical authority.
• Developer: may deploy approved content but must not bypass approval or silently alter legal meaning.

Editorial rules

Content must be plain English, dated where time-sensitive, inclusive, accessible and limited to Elevis functionality. It must not diagnose, recommend dose changes, present support staff or AI as clinicians, conceal sponsorship, or copy protected material without permission. Emergency signposting must remain prominent where relevant.

Lifecycle

Every managed item has an owner, status, last-reviewed date and review date. High-risk safety and legal content is reviewed at least every six months and after relevant product or regulatory change; ordinary help content at least annually. Corrections are prioritised by potential harm. Superseded legal versions and material approvals are retained for accountability.

User and support content

Staff may moderate unlawful, malicious, secret-bearing or abusive content using least-privilege access and an audit trail. Obvious credentials should be redacted. Material decisions, removals and escalations require a reason. Users can report inaccurate or inaccessible content to support@elevis.co.uk.